PDB Short entry for 2WEA HEADER HYDROLASE 03-FEB-98 2WEA TITLE ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH TITLE 2 PHOSPHONATE INHIBITOR: METHYL[CYCLO-7[(2R)-((N-VALYL) AMINO)-2- TITLE 3 (HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY) PHOSPHINYLOXY- TITLE 4 ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT COMPND MOL_ID: 1; COMPND 2 MOLECULE: PENICILLOPEPSIN; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.23.20 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PENICILLIUM JANTHINELLUM; SOURCE 3 ORGANISM_TAXID: 5079 KEYWDS PENICILLOPEPSIN, PHOSPHONATE INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.DING,M.E.FRASER,M.N.G.JAMES REVDAT 4 29-JUL-20 2WEA 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 04-APR-18 2WEA 1 REMARK REVDAT 2 24-FEB-09 2WEA 1 VERSN REVDAT 1 27-MAY-98 2WEA 0 SPRSDE 27-MAY-98 2WEA 1WEA JRNL AUTH J.DING,M.E.FRASER,J.H.MEYER,P.A.BARTLETT,M.N.G.JAMES JRNL TITL MACROCYCLIC INHIBITORS OF PENICILLOPEPSIN. II. X-RAY JRNL TITL 2 CRYSTALLOGRAPHIC ANALYSES OF PENICILLOPEPSIN COMPLEXED WITH JRNL TITL 3 A P3-P1 MACROCYCLIC PEPTIDYL INHIBITOR AND WITH ITS TWO JRNL TITL 4 ACYCLIC ANALOGUES JRNL REF J.AM.CHEM.SOC. V. 120 4610 1998 JRNL REFN ISSN 0002-7863 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.H.MEYER,P.A.BARTLETT REMARK 1 TITL MACROCYCLIC INHIBITORS OF PENICILLOPEPSIN. I. DESIGN, REMARK 1 TITL 2 SYNTHESIS, AND EVALUATION OF AN INHIBITOR BRIDGED BETWEEN P1 REMARK 1 TITL 3 AND P3 REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH M.E.FRASER,N.C.STRYNADKA,P.A.BARTLETT,J.E.HANSON,M.N.JAMES REMARK 1 TITL CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND REMARK 1 TITL 2 TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES REMARK 1 REF BIOCHEMISTRY V. 31 5201 1992 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.N.JAMES,A.R.SIELECKI,K.HAYAKAWA,M.H.GELB REMARK 1 TITL CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND REMARK 1 TITL 2 TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND REMARK 1 TITL 3 DIFLUOROSTATONE-CONTAINING PEPTIDES REMARK 1 REF BIOCHEMISTRY V. 31 3872 1992 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. 1.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 78.0 REMARK 3 NUMBER OF REFLECTIONS : 55829 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.149 REMARK 3 R VALUE (WORKING SET) : 0.145 REMARK 3 FREE R VALUE : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.1550 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1500 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.197 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 10.00 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 58629 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2366 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 512 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 10.427 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.014 ; 1.100 ; 2501 REMARK 3 BOND ANGLES (DEGREES) : 1.454 ; 1.100 ; 3392 REMARK 3 TORSION ANGLES (DEGREES) : 15.712; 5.000 ; 1408 REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.016 ; 2.000 ; 68 REMARK 3 GENERAL PLANES (A) : 0.026 ; 3.000 ; 366 REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 1.370 ; 0.750 ; 2501 REMARK 3 NON-BONDED CONTACTS (A) : 0.030 ; 9.000 ; 59 REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : TNT REMARK 3 KSOL : 1.00 REMARK 3 BSOL : 441.6 REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : CSDX_PROTGEO.DAT, OTHERGEO.DAT, CPPP6GEO.DAT, REMARK 3 SEMTHMGEO.DAT, CONTACT.DAT REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : CSDX_PROTGEO.DAT, REMARK 3 OTHERGEO.DAT, CPPP6GEO.DAT, REMARK 3 SEMTHMGEO.DAT REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: X-PLOR AND TNT ESD FROM SIGMAA (A) : REMARK 3 0.138904 UNCERTAINTY IN RMS ERROR SQUARED : 0.001516 REMARK 4 REMARK 4 2WEA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000178744. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAR-97 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 4.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : OTHER REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS-NICOLET X100 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XENGEN REMARK 200 DATA SCALING SOFTWARE : XENGEN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 58629 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.250 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 82.2 REMARK 200 DATA REDUNDANCY : 3.470 REMARK 200 R MERGE (I) : 0.05950 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 41.2800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 40.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.05 REMARK 200 R MERGE FOR SHELL (I) : 0.14800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.180 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIFFERENCE FOURIER METHOD REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M NAC2H3O2 PH=4.4 35-40% SATURATED REMARK 280 (NH4)2SO4, PH 4.4 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 48.16500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.13500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 48.16500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.13500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 68.93096 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 58.49069 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 863 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 208 -177.75 -174.36 REMARK 500 SER A 281 55.49 -98.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CIC REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE. DBREF 2WEA A 1 323 UNP P00798 PENP_PENJA 1 323 SEQRES 1 A 323 ALA ALA SER GLY VAL ALA THR ASN THR PRO THR ALA ASN SEQRES 2 A 323 ASP GLU GLU TYR ILE THR PRO VAL THR ILE GLY GLY THR SEQRES 3 A 323 THR LEU ASN LEU ASN PHE ASP THR GLY SER ALA ASP LEU SEQRES 4 A 323 TRP VAL PHE SER THR GLU LEU PRO ALA SER GLN GLN SER SEQRES 5 A 323 GLY HIS SER VAL TYR ASN PRO SER ALA THR GLY LYS GLU SEQRES 6 A 323 LEU SER GLY TYR THR TRP SER ILE SER TYR GLY ASP GLY SEQRES 7 A 323 SER SER ALA SER GLY ASN VAL PHE THR ASP SER VAL THR SEQRES 8 A 323 VAL GLY GLY VAL THR ALA HIS GLY GLN ALA VAL GLN ALA SEQRES 9 A 323 ALA GLN GLN ILE SER ALA GLN PHE GLN GLN ASP THR ASN SEQRES 10 A 323 ASN ASP GLY LEU LEU GLY LEU ALA PHE SER SER ILE ASN SEQRES 11 A 323 THR VAL GLN PRO GLN SER GLN THR THR PHE PHE ASP THR SEQRES 12 A 323 VAL LYS SER SER LEU ALA GLN PRO LEU PHE ALA VAL ALA SEQRES 13 A 323 LEU LYS HIS GLN GLN PRO GLY VAL TYR ASP PHE GLY PHE SEQRES 14 A 323 ILE ASP SER SER LYS TYR THR GLY SER LEU THR TYR THR SEQRES 15 A 323 GLY VAL ASP ASN SER GLN GLY PHE TRP SER PHE ASN VAL SEQRES 16 A 323 ASP SER TYR THR ALA GLY SER GLN SER GLY ASP GLY PHE SEQRES 17 A 323 SER GLY ILE ALA ASP THR GLY THR THR LEU LEU LEU LEU SEQRES 18 A 323 ASP ASP SER VAL VAL SER GLN TYR TYR SER GLN VAL SER SEQRES 19 A 323 GLY ALA GLN GLN ASP SER ASN ALA GLY GLY TYR VAL PHE SEQRES 20 A 323 ASP CYS SER THR ASN LEU PRO ASP PHE SER VAL SER ILE SEQRES 21 A 323 SER GLY TYR THR ALA THR VAL PRO GLY SER LEU ILE ASN SEQRES 22 A 323 TYR GLY PRO SER GLY ASP GLY SER THR CYS LEU GLY GLY SEQRES 23 A 323 ILE GLN SER ASN SER GLY ILE GLY PHE SER ILE PHE GLY SEQRES 24 A 323 ASP ILE PHE LEU LYS SER GLN TYR VAL VAL PHE ASP SER SEQRES 25 A 323 ASP GLY PRO GLN LEU GLY PHE ALA PRO GLN ALA MODRES 2WEA SER A 3 SER GLYCOSYLATION SITE MODRES 2WEA THR A 7 THR GLYCOSYLATION SITE HET MAN A 324 11 HET MAN A 325 11 HET SO4 A 514 5 HET PP6 A 326 39 HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM SO4 SULFATE ION HETNAM PP6 METHYL[CYCLO-7[(2R)-((N-VALYL)AMINO)-2-(HYDROXYL-(1S)- HETNAM 2 PP6 1-METHYLOXYCARBONYL-2-PHENYLETHOXY)PHOSPHINYLOXY- HETNAM 3 PP6 ETHYL]-1-NAPHTHALENEACETAMIDE] FORMUL 2 MAN 2(C6 H12 O6) FORMUL 4 SO4 O4 S 2- FORMUL 5 PP6 C29 H32 N2 O7 P 1- FORMUL 6 HOH *512(H2 O) HELIX 1 1 ALA A 12 ASP A 14 5 3 HELIX 2 2 ALA A 48 GLN A 51 1 4 HELIX 3 3 PRO A 59 THR A 62 1 4 HELIX 4 4 ALA A 110 GLN A 114 1 5 HELIX 5 5 SER A 127 ILE A 129 5 3 HELIX 6 6 PHE A 140 SER A 147 1 8 HELIX 7 7 SER A 172 LYS A 174 5 3 HELIX 8 8 ASP A 223 GLN A 232 1 10 HELIX 9 9 GLY A 269 ILE A 272 1 4 HELIX 10 10 ASP A 300 SER A 305 1 6 SHEET 1 A10 LEU A 39 VAL A 41 0 SHEET 2 A10 GLY A 120 GLY A 123 -1 N LEU A 121 O TRP A 40 SHEET 3 A10 THR A 26 ASP A 33 1 N ASN A 31 O LEU A 122 SHEET 4 A10 TYR A 17 ILE A 23 -1 N ILE A 23 O THR A 26 SHEET 5 A10 GLY A 4 PRO A 10 -1 N THR A 9 O ILE A 18 SHEET 6 A10 GLY A 163 PHE A 167 -1 N PHE A 167 O GLY A 4 SHEET 7 A10 LEU A 152 ALA A 156 -1 N ALA A 156 O VAL A 164 SHEET 8 A10 GLN A 306 ASP A 311 -1 N PHE A 310 O PHE A 153 SHEET 9 A10 GLN A 316 PRO A 321 -1 N ALA A 320 O TYR A 307 SHEET 10 A10 THR A 180 GLY A 183 -1 N THR A 182 O LEU A 317 SHEET 1 B 3 THR A 70 SER A 74 0 SHEET 2 B 3 SER A 80 ASP A 88 -1 N GLY A 83 O TRP A 71 SHEET 3 B 3 GLN A 100 ILE A 108 -1 N GLN A 107 O SER A 82 SHEET 1 C 2 VAL A 90 VAL A 92 0 SHEET 2 C 2 VAL A 95 ALA A 97 -1 N ALA A 97 O VAL A 90 SHEET 1 D 3 SER A 192 VAL A 195 0 SHEET 2 D 3 PHE A 208 ALA A 212 -1 N GLY A 210 O PHE A 193 SHEET 3 D 3 SER A 296 PHE A 298 1 N SER A 296 O ILE A 211 SHEET 1 E 4 GLN A 203 ASP A 206 0 SHEET 2 E 4 SER A 197 ALA A 200 -1 N ALA A 200 O GLN A 203 SHEET 3 E 4 PHE A 256 ILE A 260 -1 N SER A 259 O SER A 197 SHEET 4 E 4 TYR A 263 VAL A 267 -1 N VAL A 267 O PHE A 256 SHEET 1 F 2 LEU A 219 LEU A 221 0 SHEET 2 F 2 ILE A 287 SER A 289 1 N GLN A 288 O LEU A 219 SHEET 1 G 2 GLN A 237 ASP A 239 0 SHEET 2 G 2 GLY A 244 VAL A 246 -1 N VAL A 246 O GLN A 237 SHEET 1 H 2 ASN A 273 PRO A 276 0 SHEET 2 H 2 CYS A 283 GLY A 285 -1 N LEU A 284 O TYR A 274 SSBOND 1 CYS A 249 CYS A 283 1555 1555 2.03 LINK OG SER A 3 C1 MAN A 324 1555 1555 1.39 LINK OG1 THR A 7 C1 MAN A 325 1555 1555 1.40 CISPEP 1 GLN A 133 PRO A 134 0 2.05 CISPEP 2 GLY A 314 PRO A 315 0 -6.63 SITE 1 CIC 2 ASP A 33 ASP A 213 CRYST1 96.330 46.270 64.590 90.00 115.10 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010381 0.000000 0.004863 0.00000 SCALE2 0.000000 0.021612 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017097 0.00000